B Douglas Smith

9PUBLICATIONS
58CO-AUTHORS
Haematological tumoursBiologically active moleculesChild language acquisitionCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for BCR-ABL B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation.

John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur

|Jan 05, 2024
Project Confirm: Accelerated Drug Approvals for CML-Response.

Kendra L Sweet, Jorge E Cortes, Jane F Apperley

|Dec 12, 2023
CML and the WHO: Why?

Ellin Berman, Neil P Shah, Michael Deninger

|Dec 22, 2022
Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia.

Kendra L Sweet, Jorge E Cortes, Jane F Apperley

|Jan 20, 2022
Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations.

Daniel A Pollyea, Courtney D DiNardo, Martha L Arellano

|Nov 15, 2021
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.

Joshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova

Pageof 2

Frequent Collaborators

3 joint publications

Jorge E Cortes

2 joint publications

Joshua F Zeidner

2 joint publications

Vivian G Oehler

2 joint publications

Jonathan A Webster